GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Evolutionary Genomics FNAM · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

About Evolutionary Genomics

Its shares trade under the ticker FNAM. It has been listed since 3 March 2011. In the fiscal year to 31 December 2020, it reported revenue of $12,500 and a net loss of $1.7m. At that date it held total assets of $4.0m and shareholders' equity of −$1.8m.

Evolutionary Genomics, Inc. is a genomics research and development company, which engages in the identification and validation of genes. The company is headquartered in Castle Rock, Colorado. The company went IPO on 2011-03-03. The firm is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. The company uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The firm has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
3 Mar 2011
Employees
2
Website
evolgen.com ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The Adapted Traits Platform identifies commercially valuable genes in plants.
  • Research projects focus on yield increases in corn and rice.
  • Analysis determines drought tolerance and pest resistance in various crops.

Weaknesses

  • The company employs only two full-time staff members currently.
  • Operations are limited to a small team in Castle Rock.
  • Minimal workforce may restrict the scale of ongoing research projects.

Opportunities

  • Expanding ATP applications to soybeans, cassava, beans, and cotton.
  • Validating genes for sugar content improvements in tomatoes.
  • Utilizing molecular evolution analysis for new agricultural trait discoveries.

Threats

  • Small employee count limits capacity for large-scale research efforts.
  • Dependence on specific crop traits may narrow market focus.
  • Limited resources could hinder rapid expansion into new agricultural sectors.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.